Tetraphase Pharmaceuticals Priced, Nasdaq: TTPH
Developing antibiotics to treat serious abdominal and urinary tract infections.
Industry: Health Care
First Day Return: 0.0%
Industry: Health Care
TTPH
Developing antibiotics to treat serious abdominal and urinary tract infections.
| IPO Data | |
|---|---|
| IPO File Date | 02/11/2013 |
| Offer Price | $7.00 |
| Price Range $8.00 - $10.00 | |
| Offer Shares (mm) | 10.7 |
| Deal Size ($mm) | $75 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 03/19/2013 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $75 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Watertown, MA, United States |
| Founded | 2006 |
| Employees at IPO | 33 |
| Website www.tphase.com | |
IPO News for Tetraphase Pharmaceuticals
Tetraphase Pharmaceuticals (TTPH) Performance
